RxDoctor Payments Data

Ashley Donaldson, MD

Pain Medicine · Provo, UTNPI 1033597257

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,396 of the $7,299 with a category attached, or 73.9%. 33 manufacturers reported payments, led by Medtronic at 25.5% of the total. Reporting peaked in 2019 at $2,789 and has fallen 74.3% since, to $718 in 2025.

$7,299in general payments, 2019–2025

Across 232 payments — averaging $31.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Abbott$2K
  • Boston Scientific$2K
  • Nevro Corp.$525
  • Biotronik NRO, Inc.$214
  • Saluda Medical Americas, Inc.$171
  • plus $1K from 27 others
$79in research payments, 2019–2025

Across 1 payment — averaging $79.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$79

What the payments were for

  • Travel & lodging$1,90326%
  • Food & beverage$5,39674%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,299 in reported general payments places this provider in the 75th percentile of 61 pain medicine providers in Utah.

See all pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$362,625
Medicare patients
541
Services billed
11,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine-PrilocaineLidocaine/Prilocaine43$741
Diclofenac Sodium19$546
Gabapentin35$478
Methocarbamol26$278
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$226
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$199
Pregabalin18$117
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$77
Tramadol Hcl14$49

Paid to pharmacies, not to this prescriber.

Other pain medicine in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →